Tieszer C, Reid G, Denstedt J
Department of Microbiology and Immunology, The University of Western Ontario, and the Lawson Research Institute, London, Canada.
J Urol. 1998 Sep;160(3 Pt 1):876-81. doi: 10.1016/S0022-5347(01)62825-8.
Three types of ureteral stents were used in a study of 53 patients. Following extracorporeal shock wave lithotripsy, the stents were implanted and retained for periods of between 3 and 40 days. Each patient received daily antibiotic therapy with either ciprofloxacin or trimethoprim. After removal, the devices were analyzed for adherent bacteria and encrustations. The study showed that a conditioning film became deposited onto the stents upon implantation, changing the surface characteristics of the biomaterials. Dense encrustations were found to be least on a low surface energy device. No differences were found related to patient age and gender or duration of stent insertion. Flakiness and apparent sloughing of the stent surfaces was observed in some devices, raising concerns as to what actually happens to medical devices when exposed to the host urinary tract. Bacteria were recovered from the urine of three patients and the stents of four patients treated with trimethoprim. Five stents had bacterial biofilms detected by SEM. The actual clinical end-point was not the focus of this study, but no patients became septic. Our goal was to demonstrate conclusively in humans that medical devices do develop conditioning films upon implantation, and that they can be susceptible to bacterial colonization even during antibiotic treatments. The kidneys of stented patients are clearly at risk of infection, and only by proper selection of a stent type and appropriate antibiotic coverage can this risk be significantly reduced.
在一项针对53名患者的研究中使用了三种类型的输尿管支架。在体外冲击波碎石术后,植入支架并保留3至40天。每位患者每天接受环丙沙星或甲氧苄啶抗生素治疗。取出后,对装置进行粘附细菌和结痂分析。研究表明,植入时支架上会形成一层调理膜,改变了生物材料的表面特性。发现低表面能装置上的致密结痂最少。未发现与患者年龄、性别或支架插入持续时间有关的差异。在一些装置中观察到支架表面有片状剥落和明显的脱落现象,这引发了人们对医疗器械暴露于宿主尿路时实际会发生什么的担忧。从三名患者的尿液和四名接受甲氧苄啶治疗患者的支架中培养出了细菌。通过扫描电子显微镜检测到五个支架有细菌生物膜。本研究的重点并非实际的临床终点,但没有患者发生败血症。我们的目标是在人体中确凿地证明医疗器械在植入时确实会形成调理膜,并且即使在抗生素治疗期间它们也可能易受细菌定植影响。置入支架患者的肾脏显然有感染风险,只有通过正确选择支架类型和适当的抗生素覆盖才能显著降低这种风险。